Managing osteoporosis

Drug and Therapeutics Bulletin

Volumn 34, Issue 6, 1996, Pages 45-48

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; ESTROGEN; ETIDRONIC ACID; FLUORIDE SODIUM; SALCATONIN; VITAMIN D;

ABDOMINAL PAIN; BONE DENSITY; BONE MINERAL; BONE PAIN; CALCIUM INTAKE; DIARRHEA; DYSPEPSIA; ESOPHAGITIS; ESOPHAGUS ULCER; ESTROGEN THERAPY; EXERCISE; FEMALE; FLUSHING; FRACTURE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MALE; MEDICAL ASSESSMENT; NAUSEA; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; SENSORY DYSFUNCTION; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION; VITAMIN INTAKE; VOMITING;

EID: 0029973356     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.1996.34645     Document Type: Short Survey

References (34)

1. Compston JE, Cooper C, Kanis JA. Bone densitometry in clinical practice. BMJ 1995; 310: 1507-10.
2. Kanis JA, Melton, III LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137-41.
3. Krall EA, Dawson-Hughes B. Heritable and life-style determinants of bone mineral density. J Bone Miner Res 1993; 8: 1-9.
4. Compston JE. Risk factors for osteoporosis. Clin Endocrinol 1992; 36: 223-4.
5. Scane AC, Francis RM. Risk factors for osteoporosis in men. Clin Endocrinol 1993; 38: 15-6.
6. WHO (Study Group). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva: World Health Organisiation, 1994.
7. Osteoporosis: prevention and treatment. DTB 1989; 27: 1-4.
8. Nelson ME, Fiatarone MA, Morganti CM, Trice I, Greenberg RA, Evans WJ. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. JAMA 1994; 272: 1909-14.
9. Lindsay R. Prevention and treatment of osteoporosis. Lancet 1993; 341: 801-5.
10. Riggs BL, Melton III LJ. The prevention and treatment of osteoporosis. N Engl J Med 1992; 327: 620-7.
11. Stevenson JC, Cust MP, Gangar KF, Hillard TC, Lees B, Whitehead MI. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet 1990; 336: 265-9.
12. Lindsay R, Tohme JF. Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Cynecol 1990; 76: 290-5.
13. Lufkin EG, Wahner HW, O'Fallon WM et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992; 117: 1-9.
14. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PWF, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993, 329: 1141-6.
15. Holland EFN, Leather AT, Studd JWW. Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants. Br J Obstet Gynaecol 1995; 102: 238-42.
16. Magos AL, Brincat M, Studd JWW, Wardle P, Schlesinger P, O'Dowd T. Arnenorrhea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women. Obstet Gynecol 1985; 65: 496-9.
17. Etidronate for vertebral osteoporosis after the menopause. DTB 1992; 30: 45-6.
18. Harris ST, Watts NB, Jackson RD et al. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med 1993; 95: 557-67.
19. Liberman UA, Weiss SR, Broll J et al. Effect of oral alendronate on bone mineral density and the incidence of fracrures in postmenopausal osteoporosis. N Engl J Med 1995; 333: 1437-43.
20. Francis RM, Anderson FH, Torgerson DJ. A comparison of the effectiveness and cost of treatment for vertebral fractures in women. Br J Rheumatol 1995; 34: 116-71.
21. Overgaard K, Hansen MA, Jensen SB, Christiansen C. Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ 1992; 305: 556-61.
22. Rico H, Hernandez ER, Revilla M, Gomez-Castresana F. Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome. Bone Miner 1992; 16: 131-8.
23. Pun KK, Chan LWL. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. Clin Ther 1989; 11: 205-9.
24. 3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327: 1637-42.
25. Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll LJ, Falconer G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991; 115: 505-12.
26. Ooms ME, Roos JC, Bezemer PD, Van der Vijgh WJF, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women, a randomised double-blind trial. J Clin Endocrinol Metab 1995; 80: 1052-8.
27. Heikinheimo RJ, Inkovaara JA, Harju EJ et al. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 1992; 51: 105-10.
28. Van der Wielen RPJ, Lowik MRH, van den Berg H et al. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995; 346: 207-10.
29. Tilyard MW, Spears GFS, Thompson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992, 326: 357-62.
30. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990; 323: 878-83.
31. Prince RL, Smith M, Dick IM et al. Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl J Med 1991; 325: 1189-95.
32. Chesnut III CH, Ivey JL, Gruber HE et al. Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism 1983; 32: 571-80.
33. Need AG, Chatterton BE, Walker CJ, Steurer TA, Horowitz M, Nordin BEC. Comparison of calcium, calcitriol, ovarian hormones and nandrolone in the treatment of osteoporosis. Maturitas 1986; 8: 275-80.
34. Pak CYC, Sakhaee K, Adams-Huet B, Piziak V, Peterson RD, Poindexter JR. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial. Ann Intern Med 1995; 123: 401-8.